These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32590435)

  • 1. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting.
    Loh J; Kennedy MC; Wood E; Kerr T; Marshall B; Parashar S; Montaner J; Milloy MJ
    AIDS Care; 2016 Nov; 28(11):1448-54. PubMed ID: 27248328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.
    Richardson LA; Kerr TH; Dobrer S; Puskas CM; Guillemi SA; Montaner JS; Wood E; Milloy MJ
    AIDS; 2015 Nov; 29(18):2487-95. PubMed ID: 26558546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
    Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
    BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
    Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
    AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs.
    Adams JW; Marshall BDL; Mohd Salleh NA; Barrios R; Nolan S; Milloy MJ
    Drug Alcohol Depend; 2020 Jan; 206():107670. PubMed ID: 31711873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
    Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
    J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
    Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
    Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    Ti L; Dong H; Kerr T; Turje RB; Parashar S; Min JE; Montaner J; Wood E; Milloy MJ
    HIV Med; 2017 Sep; 18(8):580-586. PubMed ID: 28317290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.
    Kennedy MC; Kerr TH; Wood E; Shoveller JA; Montaner JSG; Milloy MS
    AIDS; 2018 May; 32(8):1059-1067. PubMed ID: 29424782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs.
    Fuster-RuizdeApodaca MJ; Castro-Granell V; Laguía A; Jaén Á; Cenoz S; Galindo MJ
    AIDS Res Ther; 2020 May; 17(1):24. PubMed ID: 32448214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Material security and adherence to antiretroviral therapy among HIV-positive people who use illicit drugs.
    Mohd Salleh NA; Van Draanen J; Nosova E; Barrios R; Milloy MJ; Richardson L
    AIDS; 2020 Jun; 34(7):1037-1045. PubMed ID: 32073444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
    Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.
    Ti L; Milloy MJ; Shannon K; Simo A; Hogg RS; Guillemi S; Montaner J; Kerr T; Wood E
    Sex Transm Infect; 2014 Aug; 90(5):418-22. PubMed ID: 24523347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.
    Kennedy MC; Kerr T; McNeil R; Parashar S; Montaner J; Wood E; Milloy MJ
    AIDS Behav; 2017 Mar; 21(3):678-687. PubMed ID: 26906022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.
    Slawson G; Milloy MJ; Balneaves L; Simo A; Guillemi S; Hogg R; Montaner J; Wood E; Kerr T
    AIDS Behav; 2015 Jan; 19(1):120-7. PubMed ID: 25012624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.
    Ickowicz S; Salleh NAM; Fairbairn N; Richardson L; Small W; Milloy MJ
    AIDS Behav; 2019 Sep; 23(9):2634-2639. PubMed ID: 31236749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.